Aurobindo Pharma reports 8% rise in Q3 consolidated net profit

10 Feb 2026 Evaluate

Aurobindo Pharma has reported results for third quarter ended December 31, 2025 (Q3FY26).

The company has reported 23.31% rise in its net profit at Rs 582.07 crore for the third quarter ended December 31, 2025 as compared to Rs 472.05 crore for the same quarter in the previous year. However, total income of the company decreased by 3.15% at Rs 2,877.43 crore for Q3FY26 as compared to Rs 2,970.89 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 7.62% rise in its net profit at Rs 910.29 crore for the third quarter ended December 31, 2025 as compared to Rs 845.81 crore for the same quarter in the previous year. The total income of the company increased by 8.58% at Rs 8,833.54 crore for Q3FY26 as compared to Rs 8,135.81 crore for the corresponding quarter previous year.

Aurobindo Pharma Share Price

1152.55 -23.20 (-1.97%)
20-Feb-2026 14:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1724.80
Dr. Reddys Lab 1286.15
Cipla 1340.10
Zydus Lifesciences 903.10
Lupin 2218.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×